Skip to content

Grifols S.A. Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 3, 2026 results vs estimates

Grifols S.A. · E.GRF.MC · Spain
Use symbol E.GRF.MC in our API & Excel add-in to retrieve this data ↓
11.00
(+0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 28.95%

Grifols S.A. Forecast

Grifols S.A. short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 28.9% a year, a typical one-standard-deviation range is 10.55–11.45 over a week, 10.08–11.92 over a month and 7.8159–14.18 over a year. (Signals as of 4 Nov 2026.)

Grifols S.A. Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Grifols S.A.
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Grifols S.A.
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Grifols S.A.
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Grifols S.A.
P/E
15.37x
Cheap vs own history
QoQ +3.0%
YoY −17.0%
now 15.36813.32 low20.07 high
ⓘP/E As of 22 Nov 2026.See Grifols S.A. returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Grifols S.A.
P/S
0.99x
Mid-range vs own history
QoQ +8.4%
YoY +7.3%
now 0.98560.8 low1.04 high
ⓘP/S As of 22 Nov 2026.See Grifols S.A. returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Grifols S.A.
P/B
1.29x
Mid-range vs own history
QoQ +6.3%
YoY −3.0%
now 1.29341.09 low1.49 high
ⓘP/B As of 22 Nov 2026.See Grifols S.A. returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Grifols S.A.
EV/EBITDA
8.92x
Mid-range vs own history
QoQ +5.9%
YoY +122.4%
now 8.92284.16 low9.83 high
ⓘEV/EBITDA As of 22 Nov 2026.See Grifols S.A. returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Grifols S.A.
EV/Sales
2.11x
Mid-range vs own history
QoQ +6.3%
YoY +121.8%
now 2.11050.99 low2.21 high
ⓘEV/Sales As of 22 Nov 2026.See Grifols S.A. returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Grifols S.A.
FCF Yield
10.0%
Mid-range vs own history
QoQ −11.8%
YoY −18.7%
now 10.02239.46 low13.03 high
ⓘFCF Yield As of 22 Nov 2026.See Grifols S.A. returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Grifols S.A.
Earnings Yield
6.5%
Strong vs own history
QoQ −2.9%
YoY +20.5%
now 6.5074.98 low7.51 high
ⓘEarnings Yield As of 22 Nov 2026.See Grifols S.A. returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Grifols S.A.
Market Cap
$7.5B
Mid-range vs own history
QoQ +11.0%
YoY +8.4%
now 7486.38556,003 low7,929 high
ⓘMarket Cap As of 22 Nov 2026.See Grifols S.A. returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Grifols S.A.
Net Debt
$8.5B
Mid-range vs own history
QoQ +7.0%
YoY +3,297.4%
now 8545251.52 low8,911 high
ⓘNet Debt As of 22 Nov 2026.See Grifols S.A. returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Grifols S.A.
Net Debt / EBITDA
4.76x
Mid-range vs own history
QoQ +4.1%
YoY +3,271.7%
now 4.7560.14 low5.42 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Grifols S.A. returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Grifols S.A.
Current Ratio
2.33x
Mid-range vs own history
QoQ −1.8%
YoY −6.2%
now 2.3292.33 low2.51 high
ⓘCurrent Ratio As of 22 Nov 2026.See Grifols S.A. returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Grifols S.A.
Quick Ratio
0.82x
Mid-range vs own history
QoQ +0.8%
YoY −11.9%
now 0.81740.81 low0.93 high
ⓘQuick Ratio As of 22 Nov 2026.See Grifols S.A. returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Grifols S.A.
Interest Coverage
2.53x
Strong vs own history
QoQ +3.4%
YoY +17.1%
now 2.52871.97 low2.53 high
ⓘInterest Coverage As of 22 Nov 2026.See Grifols S.A. returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Grifols S.A.
Debt / Equity
1.60x
Mid-range vs own history
QoQ +4.0%
YoY +667.7%
now 1.59640.21 low1.83 high
ⓘDebt / Equity As of 22 Nov 2026.See Grifols S.A. returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Grifols S.A.
Piotroski F-Score
6
Mid-range vs own history
QoQ −14.3%
YoY −25.0%
now 65 low8 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Grifols S.A. returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Grifols S.A.
Altman Z-Score
1.17
Strong vs own history
QoQ +5.0%
YoY +2.2%
now 1.17361.06 low1.2 high
ⓘAltman Z-Score As of 22 Nov 2026.See Grifols S.A. returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  18 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  16 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Grifols S.A., red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Grifols S.A. fundamentals: income statement, balance sheet & cash flow

Grifols S.A. reported revenue of €7.52bn and net income of €401.9m in FY2025, the year ended 31 December 2025 — revenue up 4.3% and net income up 156.1% on the prior year. Free cash flow was €624.0m. These figures are as reported in the filings, not restated: 22 fiscal years and 65 quarters of history, back to December 2004.

Revenue (FY2025)
€7.52bn
+4.3%
Net income
€401.9m
+156.1%
Gross margin
35.70%
Free cash flow
€624.0m
-6.8%
Net debt
€8.82bn
Grifols S.A. income statement, annual, as reported · EUR millions unless stated
EUR millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue7,524.27,212.46,592.06,064.04,933.1
Cost of revenue4,838.04,364.74,097.43,832.42,970.5
Gross profit2,686.02,847.72,494.62,231.51,962.6
Research & development426.0384.0330.6361.1354.9
Operating income1,236.01,192.0737.9805.7595.1
EBITDA1,686.01,757.51,186.11,213.7944.0
Interest expense625.0714.8596.9496.5278.0
Pre-tax income615.1444.0224.0361.3350.5
Income tax114.6231.243.390.185.1
Net income401.9156.959.3208.3265.3

Download Grifols S.A. fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.GRF.MC&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 22 fiscal years and 65 quarters, the filing vintages behind each number and API access.
Create free account

Figures in EUR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Grifols S.A.

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Grifols S.A. Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to Grifols S.A.; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How Grifols S.A.’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Grifols S.A. behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Grifols S.A. (Spain)

Grifols S.A. is a listed security in Spain. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Eagle Capital Growth Fund Inc

Frequently asked questions

What is Grifols S.A.?
Grifols S.A. is a listed security in Spain. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Grifols S.A. price?
The latest close is 11 (4 Nov 2026), +0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Grifols S.A. in an uptrend?
As of 4 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Grifols S.A.?
20-day realised volatility is 28.9% a year (4 Nov 2026), which implies a typical one-standard-deviation move of about 8.4% over a month and 4.1% over a week.
What factors affect Grifols S.A.?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Grifols S.A., grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Grifols S.A.?
9 backtested tactical asset allocation strategies trade Grifols S.A. through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Grifols S.A. returns analysed?
The Statistical Distribution of Returns section shows the distribution of Grifols S.A. daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Grifols S.A. historical data?
In the Free historical data section of this page: the last 10 years of Grifols S.A. daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Grifols S.A. historical data (last 10 years)

Browse or instantly download the last 10 years of Grifols S.A. daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.GRF.MC&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2010.905
2026-11-1911.06
2026-11-1811.41
2026-11-1711.53
2026-11-1611.605
2026-11-1311.65
2026-11-1211.66
2026-11-1111.48
2026-11-1011.375
2026-11-0911.38
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas; and markets diagnostic testing equipment, reagents, and other equipment, as well as provides transfusion medicine, clinical diagnostics, and testing services. It also offers biological products, including albumin, albumin-derived products, immunoglobulins, thrombin, other proteins, and intermediate plasma products to pharma and biotech companies for biopharma use; and whole blood, blood components, processed plasma, and clinical samples to life-science research and in-vitro diagnostic companies for diagnostic use. In addition, the company provides healthcare solutions for hospitals, such as intravenous solutions to maintain or restore fluids and electrolyte balance in patients; high-tech solutions to automate hospital processes; clinical nutrition to deliver nutrition and medication; and medical devices comprising instrumentation and disposable materials for various hospital services, which include interventional neuroradiology, hemodynamics, urology, anesthesiology and cardiovascular surgery, as well as manufacturing services to third parties and research activities. Further, it is involved in engineering services; packaging, labelling, storage, distribution, manufacturing, and development of pharmaceutical products; import, export, and commercialization activities; travel agency services; reinsurance of insurance policies; support services; law business; and consultation, administration, and financing services. The company was founded in 1909 and is headquartered in Barcelona, Spain.